Jobs in Cambridge

Executive Medical Director, Clinical Development Lead - Oncology GU

Serves as the enterprise clinical strategy leader for a genitourinary oncology asset, owning the clinical roadmap, benefit-risk framework and scientific narrative across the full lifecycle. Acts as the senior clinical voice on the Medicine Development Team core quad, leading governance and investment discussions and representing Clinical Development in Health Authority interactions. Study-level delivery is led by Senior Scientists, with the role focused on strategy, AI-enabled decision-making and mentoring clinical talent.

GSK Zug, Switzerland US$284,250 – US$473,750 pa

Hybrid

Medical Director-Oncology Clinical Development - GI

Serves as the physician within a clinical programme team, leading medical monitoring, safety oversight and data interpretation for GI oncology studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement. Requires an on-site presence 2-3 days a week across UK, Swiss or US sites.

GSK Zug, Switzerland US$222,750 – US$371,250 pa

Hybrid

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.

GSK London US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds relationships with key external experts and represents the company at advisory boards and medical meetings.

GSK Waltham, United States US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

GSK Stevenage US$284,250 – US$473,750 pa

On-site

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development for GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and represents the company at advisory boards and medical meetings.

GSK Zug, Switzerland US$284,250 – US$473,750 pa

On-site

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Sets disease-area strategy, chairs governance forums and scientific advisory boards, and line-manages clinical development leads and medical directors within a global matrix team.

GSK Waltham, United States

Hybrid

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Provides portfolio oversight, chairs governance forums and scientific advisory boards, and line-manages Clinical Development Leads and Medical Directors within a global matrix team.

GSK Stevenage

Hybrid

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

Leads end-to-end clinical development strategy for a hematology oncology portfolio, from first-in-human studies through registrational trials, regulatory approval and initial launch. Provides program oversight at governance forums, co-leads asset development with matrix partners, and line-manages Clinical Development Leads, Medical Directors and Clinical Scientists. Champions novel approaches such as AI/ML, innovative trial designs and real-world data.

GSK London

Hybrid

Senior Medical Director, Oncology Clinical Development - GU

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety data review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds key external expert relationships and contributes to business development diligence.

GSK USA - Pennsylvania - Upper Providence US$284,250 – US$473,750 pa

On-site

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, approval and launch. Sets disease-area strategy, chairs governance forums and advisory boards, and line-manages clinical development leads within a global matrix. Distinct for its portfolio-level enterprise scope and hybrid US/UK/Swiss base.

GSK Upper Providence

Hybrid

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and initial launch. Chairs governance forums, co-leads matrix asset teams and line-manages clinical development leads, medical directors and clinical scientists. Distinct for its portfolio-level scope across early- and late-phase programs and its cross-functional connector role spanning research, translational medicine and commercial strategy.

GSK Baar Onyx

Hybrid

Associate Director - Global Regulatory Affairs (Oncology Therapeutic Group)

Develops and executes global and regional regulatory strategies for oncology assets, ensuring optimal labelling and approvals while maintaining compliance. Partners with the Global Regulatory Lead and cross-functional teams to shape development plans and regulatory interactions across multiple regions, assessing regulatory intelligence and competitive landscape to inform decisions.

GSK Stevenage €98,250 – €163,750 pa

Hybrid

Statistics Leader (Oncology)

Manages statistical planning and delivery across oncology clinical programs, designing trials and analyses that shape development decisions and regulatory strategy. Works with clinical, regulatory, safety and clinical pharmacology teams, using simulation and advanced methods such as Bayesian and adaptive designs, while mentoring statisticians.

GSK Stevenage

Data-Flow Specialist

Designs, builds and maintains modular end-to-end data-flows across GSK's R&D division, integrating scattered systems and sources into reusable, machine-readable assets with compliance built into the pipeline. Combines hands-on coding and data specification work with coaching and peer review to raise the team's data-flow standards.

GSK Stevenage

On-site Permanent